search
Back to results

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (Agility)

Primary Purpose

Melanoma

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
AEP Group Walking Sessions
CEP Group Walking Sessions
Sponsored by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Melanoma focused on measuring Primary Melanoma

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age from 18 to 65 years at the time of recruitment Histologically confirmed diagnosis of primary melanoma Patients who are candidate to curative surgery for primary melanoma, skin radicalization or sentinel node biopsy. American Society of Anaesthesiologists (ASA) status I Willingness and ability to comply with the protocol, the scheduled visits, treatment plans, laboratory tests and other procedures. Understanding and signature of the informed consent Female patients of childbearing potential must agree to sexual abstinence or to use highly effective method of contraception throughout the study (for CEP patients) Exclusion Criteria: American Society of Anaesthesiologists (ASA) status > I Pregnancy or lactation Known infection from HIV virus Regular physical exercise (more than 1 exercise workout of moderate to intense exercise activity per week) Any physical or mental conditions interfering with the ability to perform exercise or to complete the testing procedures.

Sites / Locations

  • Fondazione IRCCS Istituto Nazionale dei TumoriRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

AEP Group

CEP Group

Arm Description

First series of patients (10 pts) will be assigned to the Acute Exercise Protocol Group (AEP Group). The acute program consists in a single walking session on a treadmill lasting 80 minutes. The exercise session will begin with a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, treadmill speed will be increased until reaching target HRR zone. Then the treadmill speed will be maintained stable throughout the exercise session. Cardiac workload will be monitored by a Sport-watch (Garmin Forerunner) and the walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore).

Second series of patients (10 pts) will be assigned to the Chronic Exercise Protocol Group (CEP Group). The chronic program consists in a walking session on a treadmill lasting 80 minutes (depending on the AEP results), repeated three time a week for three weeks. The walking intensity will be defined during a treadmill test performedbefore the beginning of the exercise program. Each exercise session will beginwith a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, patients will increase treadmill speed until reaching target HRR zone.Then the treadmill speed will be maintained stable throughout the exercise session. The first training session will be organized in hospital with supervision of research staff. Cardiac workload will be monitored by a Sport-watch (Garmin Forerunner) and walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore).

Outcomes

Primary Outcome Measures

Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Analysis of the "systemic metabolic milieu"_AEPMet before
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor before
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf before
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip before
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts before
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 40
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 40
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 40
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 40
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 40
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 80
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 80
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 80
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 80
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 80
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 24
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 24
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 24
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 24
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 24
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 72
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 72
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 72
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 72
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 72
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet before
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor before
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf before
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip before
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEP counts before
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet 1w
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor 1w
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf 1w
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip 1w
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEPcounts 1w
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet 2w
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor 2w
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf 2w
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip 2w
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEPcounts 2w
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the metabolic parameters by capillary sampling_AEPCap before
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 40
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 80
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 24
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 72
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap before
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap 2w
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap end
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).

Secondary Outcome Measures

Full Information

First Posted
April 29, 2021
Last Updated
November 8, 2022
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
search

1. Study Identification

Unique Protocol Identification Number
NCT05615883
Brief Title
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
Acronym
Agility
Official Title
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 20, 2020 (Actual)
Primary Completion Date
February 28, 2023 (Anticipated)
Study Completion Date
March 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is designed to investigate the effects of ketogenic milieu induced by acute exercise as well as the effects of recurrent exercise bouts on functional status and the accumulation in peripheral blood of MDSCs and the consequent balance on antitumor immunity in melanoma patients.
Detailed Description
The screening period starts once a patient has provided written informed consent to participate in the study and ends on the day of exercise initiation. Screening assessments have to be done within 28 days prior to exercise initiation. The informed consent will adhere to IRB/ERC requirements, applicable laws and regulations. After the sign of an informed consensus, patients will be assigned to a specific exercise program. The first series of patients will be assigned to the Acute Exercise Program (AEP group), the second series to the Chronic Exercise Program (CEP group). The protocol will be implemented in the time between diagnosis and surgical intervention without any delay in the therapeutic pathway. Basal evaluation: patient's life style will be investigated using the short version of Physical Activity Questionnaire (Italian version) and MeDiet questionnaire. Age, weight and eight will be registered for all patients. The Lean Body Mass will be measured by Dual Energy X-ray Absorptiometry (DEXA). A cardiorespiratory test will be performed to calculate an appropriate exercise intensity and subsequently the Six Minutes WalkingTest and the Comfortable Walking Speed test will be run before exercise protocol. In the CEP group the DEXA and the walking tests will be repeated after the end of exercise program. Exercise prescription: the physical exercise consists in walking at a brisk pace. In order to produce a constant metabolic stress in patients with different aerobic power, walking intensity will be prescribed in accordance with the method of the Heart Rate Reserve (HRR), ie difference between resting heart rate (HR-resting) and the heart rate corresponding to muscle's maximal oxygen uptake (HR-max). This prescribing method is based on the linear relationship between heart rate reserve and muscle workload calculated as a percentage of the difference between resting and maximum muscle oxygen consumption (VO2R%). The training intensity will be set to the 30% HRR, the lowest intensity that produces a training effect. To minimize the impact of the research protocol on the patient's therapeutic path, the investigators refrain from the execution of a Cardio Pulmonary Exercise Test and therefore opted for calculating the HR-max using the ACSM formula. Given the entry criteria of this study the investigators believe this choice will minimally affect the exercise-dose prescription and study results. Acute Exercise Protocol (AEP): The acute program consists in a single walking session on a treadmill lasting 80 minutes. The exercise session will begin with a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, treadmill speed will be increased until reaching target HRR zone. Then the treadmill speed will be maintained stable throughout the exercise session. Cardiac workload will be monitored by a Sport-watch (Garmin Forerunner 35) and the walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore). Chronic Exercise Protocol (CEP): The chronic program consists in a walking session on a treadmill lasting 80 minutes (depending on the AEP results), repeated three time a week for three weeks. The walking intensity will be defined during a treadmill test performed before the beginning of the exercise program. Each exercise session will begin with a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, patients will increase treadmill speed until reaching target HRR zone. Then the treadmill speed will be maintained stable throughout the exercise session. The first training session will be organized in hospital with supervision of research staff. Cardiac workload will be monitored by a Sport-watch(Garmin Forerunner 35) and walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore). Diet intervention: Modifications occurring during AEP strictly depend on the baseline metabolic conditions. For this reason, patients must remain fasting for 4 hours before the workout and avoid glucose rich foodies for 120 minutes after the end of exercise session in CEP group. During the exercise session patients will have free access to water only. All patients will complete a food diary during the study period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Melanoma
Keywords
Primary Melanoma

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Pre/post intervention, two-arms, sequential study. Patients with newly diagnose of melanoma are eligible.The study will enroll a total of 20 patients (10 in the AEP and 10 in the CEP), who will be enrolled approximately in 12-13 months.The first series of patients will be assigned to the Acute Exercise Program (AEP group), the second series to the Chronic Exercise Program (CEP group). The final endpoint is to verify whether short-term physical exercise can represent a feasible and safe tool for re-setting antitumor immunity in early melanoma patients. Investigators will analyze how the acute physical exercise modifies systemic immunity and biochemical/metabolic parameters. Specifically, Investigators will verify whether the exercise will modify:1 the immunological profiling of blood including frequency and function of MDSC, together with the concomitant status of antitumor immunity; 2 blood concentration of biochemical and metabolic parameters related to physical exercise and immunity
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
AEP Group
Arm Type
Experimental
Arm Description
First series of patients (10 pts) will be assigned to the Acute Exercise Protocol Group (AEP Group). The acute program consists in a single walking session on a treadmill lasting 80 minutes. The exercise session will begin with a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, treadmill speed will be increased until reaching target HRR zone. Then the treadmill speed will be maintained stable throughout the exercise session. Cardiac workload will be monitored by a Sport-watch (Garmin Forerunner) and the walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore).
Arm Title
CEP Group
Arm Type
Experimental
Arm Description
Second series of patients (10 pts) will be assigned to the Chronic Exercise Protocol Group (CEP Group). The chronic program consists in a walking session on a treadmill lasting 80 minutes (depending on the AEP results), repeated three time a week for three weeks. The walking intensity will be defined during a treadmill test performedbefore the beginning of the exercise program. Each exercise session will beginwith a 10-minute warm-up at the patient's self selected comfortable speed. On the ending of warm up, patients will increase treadmill speed until reaching target HRR zone.Then the treadmill speed will be maintained stable throughout the exercise session. The first training session will be organized in hospital with supervision of research staff. Cardiac workload will be monitored by a Sport-watch (Garmin Forerunner) and walking biomechanics by a foot sensor (Garmin Running Dynamic Pod Sensore).
Intervention Type
Other
Intervention Name(s)
AEP Group Walking Sessions
Intervention Description
The AEP Program consists in a single walking session on a treadmill lasting 80 minutes
Intervention Type
Other
Intervention Name(s)
CEP Group Walking Sessions
Intervention Description
The chronic program consists in a walking session on a treadmill lasting 80 minutes (depending on the AEP results), repeated three time a week for three weeks.
Primary Outcome Measure Information:
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
AEP group: before exercise session.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
AEP group: at 24 post-exercise.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
AEP group: at 72 hours post-exercise.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
CEP group: before exercise program.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
CEP group: after one week of exercise program.
Title
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Time Frame
CEP group: up to two weeks of exercise program.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
AEP group: before exercise.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
AEP group: after 40 minutes of exercise session
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
AEP group: at 24 post-exercise.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
AEP group: at 72 hours post-exercise.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
CEP group: before exercise program.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
CEP group: after one week of exercise program.
Title
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Description
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Time Frame
CEP group: up to two weeks of exercise program.
Title
Analysis of the "systemic metabolic milieu"_AEPMet before
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
AEP group: before exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPHor before
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
AEP group: before exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPInf before
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
AEP group: before exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPLip before
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
AEP group: before exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPcounts before
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
AEP group: before exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPMet 40
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPHor 40
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPInf 40
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPLip 40
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPcounts 40
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPMet 80
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPHor 80
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPInf 80
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPLip 80
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPcounts 80
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the "systemic metabolic milieu"_AEPMet 24
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPHor 24
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPInf 24
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPLip 24
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPcounts 24
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPMet 72
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPHor 72
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPInf 72
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPLip 72
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the "systemic metabolic milieu"_AEPcounts 72
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the "systemic metabolic milieu"_CEPMet before
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
CEP group: before exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPHor before
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
CEP group: before exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPInf before
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
CEP group: before exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPLip before
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
CEP group: before exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEP counts before
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
CEP group: before exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPMet 1w
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
CEP group: after one week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPHor 1w
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
CEP group: after one week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPInf 1w
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
CEP group: after one week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPLip 1w
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
CEP group: after one week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPcounts 1w
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
CEP group: after one week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPMet 2w
Description
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Time Frame
CEP group: up to two week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPHor 2w
Description
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Time Frame
CEP group: up to two week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPInf 2w
Description
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Time Frame
CEP group: up to two week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPLip 2w
Description
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Time Frame
CEP group: up to two week of exercise program.
Title
Analysis of the "systemic metabolic milieu"_CEPcounts 2w
Description
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Time Frame
CEP group: up to two week of exercise program.
Title
Analysis of the metabolic parameters by capillary sampling_AEPCap before
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
AEP group: before exercise session.
Title
Analysis of the metabolic parameters by capillary sampling_AEPCap 40
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
AEP group: after 40 minutes of exercise session.
Title
Analysis of the metabolic parameters by capillary sampling_AEPCap 80
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
AEP group: after 80 minutes of exercise session.
Title
Analysis of the metabolic parameters by capillary sampling_AEPCap 24
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
AEP group: at 24 post-exercise.
Title
Analysis of the metabolic parameters by capillary sampling_AEPCap 72
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
AEP group: at 72 hours post-exercise.
Title
Analysis of the metabolic parameters by capillary sampling_CEPCap before
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
CEP group: during the first training session
Title
Analysis of the metabolic parameters by capillary sampling_CEPCap 2w
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
CEP group: every morning up to two weeks.
Title
Analysis of the metabolic parameters by capillary sampling_CEPCap end
Description
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Time Frame
CEP group: at the end of training sessions up to two weeks.
Other Pre-specified Outcome Measures:
Title
Physical Activity Questionnaire
Description
Patient's life style will be investigated using the short version of Physical Activity Questionnaire
Time Frame
Within one month of the enrollment
Title
MeDiet questionnaire
Description
Patient's life style will be investigated using the short version of MeDiet questionnaire
Time Frame
Within one month of the enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age from 18 to 65 years at the time of recruitment Histologically confirmed diagnosis of primary melanoma Patients who are candidate to curative surgery for primary melanoma, skin radicalization or sentinel node biopsy. American Society of Anaesthesiologists (ASA) status I Willingness and ability to comply with the protocol, the scheduled visits, treatment plans, laboratory tests and other procedures. Understanding and signature of the informed consent Female patients of childbearing potential must agree to sexual abstinence or to use highly effective method of contraception throughout the study (for CEP patients) Exclusion Criteria: American Society of Anaesthesiologists (ASA) status > I Pregnancy or lactation Known infection from HIV virus Regular physical exercise (more than 1 exercise workout of moderate to intense exercise activity per week) Any physical or mental conditions interfering with the ability to perform exercise or to complete the testing procedures.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Licia Rivoltini, MD
Phone
+3902/23903245
Email
licia.rivoltini@istitutotumori.mi.it
First Name & Middle Initial & Last Name or Official Title & Degree
Paola Frati, PM
Phone
+3902/23903036
Email
paola.frati@istitutotumori.mi.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Licia Rivoltini, MD
Organizational Affiliation
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fondazione IRCCS Istituto Nazionale dei Tumori
City
Milan
ZIP/Postal Code
20033
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Licia Rivoltini, MD
Phone
+3902/23903245
Email
licia.rivoltini@istitutotumori.mi.it
First Name & Middle Initial & Last Name & Degree
Paola Frati
Phone
+3902/23903036
Email
paola.frati@istitutotumori.mi.it

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Since the study data could be compared with those obtained from other clinical studies, focused on the immune system, this part is not yet defined. Anyhow it will depend on the results obtained.
Citations:
PubMed Identifier
23395268
Citation
Yuan HX, Xiong Y, Guan KL. Nutrient sensing, metabolism, and cell growth control. Mol Cell. 2013 Feb 7;49(3):379-87. doi: 10.1016/j.molcel.2013.01.019.
Results Reference
background
PubMed Identifier
21963299
Citation
Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011 Dec;23(6):744-55. doi: 10.1016/j.ceb.2011.09.003. Epub 2011 Sep 29.
Results Reference
background
PubMed Identifier
28475890
Citation
Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction of Immunity. Cell. 2017 May 4;169(4):570-586. doi: 10.1016/j.cell.2017.04.004.
Results Reference
background
PubMed Identifier
26377897
Citation
Biswas SK. Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity. 2015 Sep 15;43(3):435-49. doi: 10.1016/j.immuni.2015.09.001.
Results Reference
background
PubMed Identifier
24440038
Citation
Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014 Feb 4;19(2):181-92. doi: 10.1016/j.cmet.2013.12.008. Epub 2014 Jan 16.
Results Reference
background
PubMed Identifier
22120756
Citation
Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother. 2012 Feb;61(2):255-263. doi: 10.1007/s00262-011-1161-9. Epub 2011 Nov 27.
Results Reference
background
PubMed Identifier
28492541
Citation
Jian SL, Chen WW, Su YC, Su YW, Chuang TH, Hsu SC, Huang LR. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Cell Death Dis. 2017 May 11;8(5):e2779. doi: 10.1038/cddis.2017.192.
Results Reference
background
PubMed Identifier
27757311
Citation
Trikha P, Plews RL, Stiff A, Gautam S, Hsu V, Abood D, Wesolowski R, Landi I, Mo X, Phay J, Chen CS, Byrd J, Caligiuri M, Tridandapani S, Carson W. Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator. Oncoimmunology. 2016 Jul 25;5(9):e1214787. doi: 10.1080/2162402X.2016.1214787. eCollection 2016.
Results Reference
background
PubMed Identifier
29805099
Citation
Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metab. 2018 Jul 3;28(1):87-103.e6. doi: 10.1016/j.cmet.2018.04.022. Epub 2018 May 24.
Results Reference
background
PubMed Identifier
25431226
Citation
Ball D. Metabolic and endocrine response to exercise: sympathoadrenal integration with skeletal muscle. J Endocrinol. 2015 Feb;224(2):R79-95. doi: 10.1530/JOE-14-0408. Epub 2014 Nov 27.
Results Reference
background
PubMed Identifier
18923185
Citation
Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008 Oct;88(4):1379-406. doi: 10.1152/physrev.90100.2007.
Results Reference
background
PubMed Identifier
18840763
Citation
Wasserman DH. Four grams of glucose. Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E11-21. doi: 10.1152/ajpendo.90563.2008. Epub 2008 Oct 7.
Results Reference
background
PubMed Identifier
29444266
Citation
Murray B, Rosenbloom C. Fundamentals of glycogen metabolism for coaches and athletes. Nutr Rev. 2018 Apr 1;76(4):243-259. doi: 10.1093/nutrit/nuy001.
Results Reference
background
PubMed Identifier
29344008
Citation
Purdom T, Kravitz L, Dokladny K, Mermier C. Understanding the factors that effect maximal fat oxidation. J Int Soc Sports Nutr. 2018 Jan 12;15:3. doi: 10.1186/s12970-018-0207-1. eCollection 2018.
Results Reference
background
PubMed Identifier
7928844
Citation
Brooks GA, Mercier J. Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. J Appl Physiol (1985). 1994 Jun;76(6):2253-61. doi: 10.1152/jappl.1994.76.6.2253.
Results Reference
background
PubMed Identifier
20513337
Citation
Goodwin ML. Blood glucose regulation during prolonged, submaximal, continuous exercise: a guide for clinicians. J Diabetes Sci Technol. 2010 May 1;4(3):694-705. doi: 10.1177/193229681000400325.
Results Reference
background
PubMed Identifier
28178565
Citation
Puchalska P, Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 2017 Feb 7;25(2):262-284. doi: 10.1016/j.cmet.2016.12.022.
Results Reference
background
PubMed Identifier
27861911
Citation
Evans M, Cogan KE, Egan B. Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J Physiol. 2017 May 1;595(9):2857-2871. doi: 10.1113/JP273185. Epub 2016 Dec 7.
Results Reference
background
PubMed Identifier
11739078
Citation
Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23. doi: 10.1152/ajpendo.2002.282.1.E18.
Results Reference
background
PubMed Identifier
15585585
Citation
Geiger PC, Wright DC, Han DH, Holloszy JO. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E782-8. doi: 10.1152/ajpendo.00477.2004. Epub 2004 Dec 7.
Results Reference
background
PubMed Identifier
18375791
Citation
Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N, Matsushima K. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood. 2008 Jun 15;111(12):5457-66. doi: 10.1182/blood-2008-01-136895. Epub 2008 Mar 28.
Results Reference
background
PubMed Identifier
24789911
Citation
Condamine T, Kumar V, Ramachandran IR, Youn JI, Celis E, Finnberg N, El-Deiry WS, Winograd R, Vonderheide RH, English NR, Knight SC, Yagita H, McCaffrey JC, Antonia S, Hockstein N, Witt R, Masters G, Bauer T, Gabrilovich DI. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest. 2014 Jun;124(6):2626-39. doi: 10.1172/JCI74056. Epub 2014 May 1.
Results Reference
background
PubMed Identifier
26611648
Citation
Motallebnezhad M, Jadidi-Niaragh F, Qamsari ES, Bagheri S, Gharibi T, Yousefi M. The immunobiology of myeloid-derived suppressor cells in cancer. Tumour Biol. 2016 Feb;37(2):1387-406. doi: 10.1007/s13277-015-4477-9. Epub 2015 Nov 26.
Results Reference
background
PubMed Identifier
23797066
Citation
Khaled YS, Ammori BJ, Elkord E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol. 2013 Sep;91(8):493-502. doi: 10.1038/icb.2013.29. Epub 2013 Jun 25.
Results Reference
background
PubMed Identifier
19308068
Citation
Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009 Apr;9(4):285-93. doi: 10.1038/nrc2621.
Results Reference
background
PubMed Identifier
25263083
Citation
Umansky V, Sevko A, Gebhardt C, Utikal J. Myeloid-derived suppressor cells in malignant melanoma. J Dtsch Dermatol Ges. 2014 Nov;12(11):1021-7. doi: 10.1111/ddg.12411. Epub 2014 Sep 28. English, German.
Results Reference
background
PubMed Identifier
27057203
Citation
Carruba G, Cocciadiferro L, Di Cristina A, Granata OM, Dolcemascolo C, Campisi I, Zarcone M, Cinquegrani M, Traina A. Nutrition, aging and cancer: lessons from dietary intervention studies. Immun Ageing. 2016 Apr 7;13:13. doi: 10.1186/s12979-016-0069-9. eCollection 2016.
Results Reference
background
PubMed Identifier
12091180
Citation
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.
Results Reference
background
PubMed Identifier
19856629
Citation
McCulloch KL, Mercer V, Giuliani C, Marshall S. Development of a clinical measure of dual-task performance in walking: reliability and preliminary validity of the Walking and Remembering Test. J Geriatr Phys Ther. 2009;32(1):2-9. doi: 10.1519/00139143-200932010-00002.
Results Reference
background
PubMed Identifier
20833587
Citation
da Cunha FA, Farinatti Pde T, Midgley AW. Methodological and practical application issues in exercise prescription using the heart rate reserve and oxygen uptake reserve methods. J Sci Med Sport. 2011 Jan;14(1):46-57. doi: 10.1016/j.jsams.2010.07.008. Epub 2010 Sep 15.
Results Reference
background
PubMed Identifier
23620244
Citation
Mann T, Lamberts RP, Lambert MI. Methods of prescribing relative exercise intensity: physiological and practical considerations. Sports Med. 2013 Jul;43(7):613-25. doi: 10.1007/s40279-013-0045-x.
Results Reference
background
PubMed Identifier
11782661
Citation
Swain DP, Franklin BA. VO(2) reserve and the minimal intensity for improving cardiorespiratory fitness. Med Sci Sports Exerc. 2002 Jan;34(1):152-7. doi: 10.1097/00005768-200201000-00023.
Results Reference
background
PubMed Identifier
11153730
Citation
Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001 Jan;37(1):153-6. doi: 10.1016/s0735-1097(00)01054-8.
Results Reference
background

Learn more about this trial

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

We'll reach out to this number within 24 hrs